HealthEquity (NASDAQ:HQY) Shares Cross Above 50-Day Moving Average – Here’s Why

HealthEquity, Inc. (NASDAQ:HQY)’s share price crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $85.20 and traded as high as $85.63. HealthEquity shares last traded at $83.43, with a volume of 715,138 shares.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on HQY shares. Wells Fargo & Company set a $111.00 target price on HealthEquity in a research note on Monday, June 1st. Citizens Jmp boosted their price objective on shares of HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a report on Monday, June 1st. Weiss Ratings upgraded shares of HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a report on Friday, June 5th. Royal Bank Of Canada upped their price objective on shares of HealthEquity from $100.00 to $108.00 and gave the company an “outperform” rating in a research report on Wednesday, June 3rd. Finally, Deutsche Bank Aktiengesellschaft raised their target price on HealthEquity from $120.00 to $128.00 and gave the company a “buy” rating in a research note on Thursday, March 19th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $110.57.

HealthEquity Stock Performance

The company has a fifty day moving average of $85.20 and a two-hundred day moving average of $84.74. The stock has a market capitalization of $6.97 billion, a P/E ratio of 31.25, a price-to-earnings-growth ratio of 1.43 and a beta of 0.21. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44.

HealthEquity (NASDAQ:HQY) last released its earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. The company had revenue of $354.64 million for the quarter, compared to the consensus estimate of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The company’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, equities analysts anticipate that HealthEquity, Inc. will post 3.92 EPS for the current year.

Insider Activity at HealthEquity

In related news, EVP Delano Ladd sold 7,500 shares of the firm’s stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $675,000.00. Following the transaction, the executive vice president directly owned 91,141 shares in the company, valued at $8,202,690. This trade represents a 7.60% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 3,142 shares of HealthEquity stock in a transaction on Friday, May 29th. The stock was sold at an average price of $95.00, for a total transaction of $298,490.00. Following the completion of the transaction, the executive vice president directly owned 59,113 shares of the company’s stock, valued at approximately $5,615,735. This represents a 5.05% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 13,081 shares of company stock valued at $1,193,000. Corporate insiders own 1.60% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Sivia Capital Partners LLC bought a new stake in shares of HealthEquity during the 2nd quarter valued at about $306,000. Arrowstreet Capital Limited Partnership bought a new position in HealthEquity in the second quarter worth about $4,747,000. Marshall Wace LLP acquired a new position in HealthEquity in the second quarter valued at approximately $5,483,000. Amundi boosted its stake in HealthEquity by 9.3% in the second quarter. Amundi now owns 30,203 shares of the company’s stock valued at $3,059,000 after acquiring an additional 2,574 shares during the period. Finally, Jump Financial LLC bought a new position in shares of HealthEquity during the second quarter valued at approximately $449,000. 99.55% of the stock is currently owned by institutional investors.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.